175 related articles for article (PubMed ID: 37086852)
1. An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes.
Ford CD; Hoda D; Lopansri BK; Parra M; Sharma P; Asch J
Transplant Cell Ther; 2023 Jul; 29(7):471.e1-471.e7. PubMed ID: 37086852
[TBL] [Abstract][Full Text] [Related]
2. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
[TBL] [Abstract][Full Text] [Related]
4. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
5. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients.
Austin K; Sweet M; Likar E; LaSala PR; Murray A; Wen S; Ross KG; Kanate AS; Veltri L; Matuga R; Cumpston A
Transpl Infect Dis; 2020 Dec; 22(6):e13438. PubMed ID: 32767807
[TBL] [Abstract][Full Text] [Related]
7. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation.
Callejas-Díaz A; Gea-Banacloche JC
Curr Hematol Malig Rep; 2014 Mar; 9(1):85-90. PubMed ID: 24390550
[TBL] [Abstract][Full Text] [Related]
9. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
Weber S; Scheich S; Magh A; Wolf S; Enßle JC; Brunnberg U; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Vehreschild MJGT; Serve H; Bug G; Steffen B; Hogardt M
Int J Infect Dis; 2020 Oct; 99():428-436. PubMed ID: 32798661
[TBL] [Abstract][Full Text] [Related]
10. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes.
Ford CD; Lopansri BK; Coombs J; Webb BJ; Nguyen A; Asch J; Hoda D
Clin Transplant; 2019 Nov; 33(11):e13712. PubMed ID: 31532030
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
16. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.
Chopra T; Chandrasekar P; Salimnia H; Heilbrun LK; Smith D; Alangaden GJ
Clin Transplant; 2011; 25(1):E82-7. PubMed ID: 20973823
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of
Luo Y; Zhang S; Shang H; Cui W; Wang Q; Zhu B
Front Cell Infect Microbiol; 2022; 12():801475. PubMed ID: 35265530
[TBL] [Abstract][Full Text] [Related]
18. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
Barbar R; Hayden R; Sun Y; Tang L; Hakim H
Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors and Outcome of
Rosignoli C; Petruzzellis G; Radici V; Facchin G; Girgenti M; Stella R; Isola M; Battista M; Sperotto A; Geromin A; Cerno M; Arzese A; Deias P; Tascini C; Fanin R; Patriarca F
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33207616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
